Abstract:Objective To construct a chimeric protein of antigenic epitopes from human adenovirus (HAdV) of types 3,7,11,14 and 55,express in E.coli and determine its antigenicity and immunogenicity.Methods The amino acid sequences of HAdV hexons of five types were analyzed by using the software ANTHEWIN,from which the epitopes with strong antigenicity were screened and linked together with Gly-Gly-Ser for construction of a chimeric protein.The gene sequence of the chimeric protein was optimized,synthesized chemically and cloned into prokaryotic expression vector pET-28a(+).The constructed recombinant plasmid was transformed to E.coli BL21 (DE3),and the recombinant strain for high expression of chimeric protein was screened.The expressed chimeric protein was purified by High Affinity Ni-NTA resin chromatography and used as an antigen to immunize BALB/c mice for preparation of antiserum.The antigenicity and immunogenicity of chimeric protein were determined by ELISA.Results The recombinant E.coli for high expression of chimeric protein was constructed.The expressed chimeric protein,with a relative molecular mass of 55 000,contained 95％ of total somatic protein.The purity of chimeric protein in bacterial supernatant reached more than 90％ after purification.The titer of antiserum of mice immunized with the chimeric protein for 4 times reached to 1 ∶ 320 000.The prepared chimeric protein was effective in determination of antibodies against HAdV types 3,7,11,14 and 55,and stimulated the production of antibodies against antigenic epitopes of various types.Conclusion The expressed chimeric protein of antigenic epitopes of HAdV of five types showed good antigenicity and immunogenicity,which laid a foundation of developing HAdV vaccine,monoclonal antibodies and diagnostic reagents.

[Prokaryotic Expression and Immunogenicity of the Chimeric HBcAg Containing Aβ(1-15)].

[Prokaryotic Expression and Immunogenicity Analysis of the Chimeric HBcAg Containing APP Beta Cleavage Site Peptide and Aβ(1-15);].

[Construction and Prokaryotic Expression of Recombinant Gene C-Abeta-c and the Immunogenicity Analysis of the Fusion Protein].

[Construction of Recombinant Plasmid Pyta/abeta-Hbcag and Its Expression in E.coli].

Construction of Multivalent Recombinant Aβ1-15 DNA Vaccine and Its Effect on Humoral Immune

[Biological Effects of Immune Serum from Fusion Protein of Beta-Amyloid Peptide and HbcAg/MIR on AD Transgeneic Cells].

Prokaryotic expression of fusion gene Aβ-HBcAg and analysis of the immunoreactivity and immunogenicity of the expression protein

Construction of Multivalent Recombinant Aβ42 DNA Vaccine and Induction of Aβ Antibody

Anti-A Beta Antibodies Induced By A Beta-Hbc Virus-Like Particles Prevent A Beta Aggregation And Protect Pc12 Cells Against Toxicity Of A Beta(1-40)

[Construction and Prokaryotic Expression of Recombinant Gene EGFRvIII HBcAg and Immunogenicity Analysis of the Fusion Protein].

Expression of recombinant quadrivalent Aβ1-15 and its immunogenicity identification

[Fusion Expression of Human Abeta42 Recombinant Protein and Detection of Abeta Antibody].

[The Immunization Effects of HBV Core Antigen and Surface Antigen Fusion Protein in Mice].

[Immunization with Recombinant HBcAg and Β-Amyloid Peptide Fusion Protein Promotes Clearance of Intrahippocampally Injected Β-Amyloid Peptide in Rats].

Prokaryotic expression and immunogenicity of adenovirus antigenic epitope chimeric protein

A Novel Recombinant Vaccine Against Alzheimer's Disease: Cloning, Expression, Purification and Antigenicity Evaluation

Establishment of Echinococcus Granulosus AgB8/1-AgB8/2 Chimeric Recombinant Protein Expression System

The Expression of HCG Epitope Fused to Hepatits B Virus Core Antigen.

Prokaryotic Expression and Renaturation of Engineering Chimeric Fab Antibody Against Human Hepatoma.

Expression and purification of truncated C gene combined with preS1 gene from HBV in E.coli

High Level Expression Purification and Character Research of Human Fusion Antibody for Anti-Aβ in the Yeast Pichia Pastoris